Nagashima H, Shayne J, Jiang K, Petermann F, Pekowska A, Kanno Y
Nat Immunol. 2024; 25(12):2220-2233.
PMID: 39567762
DOI: 10.1038/s41590-024-02007-4.
Montano J, Garnica J, Yamanouchi J, Moro J, Sole P, Mondal D
Front Immunol. 2024; 15:1454314.
PMID: 39315110
PMC: 11416961.
DOI: 10.3389/fimmu.2024.1454314.
Sharma P, Sethi R
J Toxicol. 2024; 2024:5261994.
PMID: 39239465
PMC: 11377118.
DOI: 10.1155/2024/5261994.
Zhou X, Xue S, Si X, Du W, Guo Y, Qu Y
CNS Neurosci Ther. 2024; 30(8):e70023.
PMID: 39205499
PMC: 11358587.
DOI: 10.1111/cns.70023.
Vickers R, Porter W
J Mammary Gland Biol Neoplasia. 2024; 29(1):16.
PMID: 39177859
PMC: 11343902.
DOI: 10.1007/s10911-024-09568-y.
Novel insights: crosstalk with non-puerperal mastitis and immunity.
Zhou Y, Gong J, Deng X, Shen L, Liu L
Front Immunol. 2024; 15:1431681.
PMID: 39148739
PMC: 11324573.
DOI: 10.3389/fimmu.2024.1431681.
Predicting gene expression state and prioritizing putative enhancers using 5hmC signal.
Gonzalez-Avalos E, Onodera A, Samaniego-Castruita D, Rao A, Ay F
Genome Biol. 2024; 25(1):142.
PMID: 38825692
PMC: 11145787.
DOI: 10.1186/s13059-024-03273-z.
Regulation of T helper cell differentiation by the interplay between histone modification and chromatin interaction.
Liu S, Cao Y, Cui K, Ren G, Zhao T, Wang X
Immunity. 2024; 57(5):987-1004.e5.
PMID: 38614090
PMC: 11096031.
DOI: 10.1016/j.immuni.2024.03.018.
The role of CD4 T cells in tumor and chronic viral immune responses.
Xie L, Fang J, Yu J, Zhang W, He Z, Ye L
MedComm (2020). 2023; 4(5):e390.
PMID: 37829505
PMC: 10565399.
DOI: 10.1002/mco2.390.
Double-edged sword of JAK/STAT signaling pathway in viral infections: novel insights into virotherapy.
Mahjoor M, Mahmoudvand G, Farokhi S, Shadab A, Kashfi M, Afkhami H
Cell Commun Signal. 2023; 21(1):272.
PMID: 37784164
PMC: 10544547.
DOI: 10.1186/s12964-023-01240-y.
HK3 stimulates immune cell infiltration to promote glioma deterioration.
Li S, Li Z, Wang X, Zhong J, Yu D, Chen H
Cancer Cell Int. 2023; 23(1):227.
PMID: 37779195
PMC: 10543879.
DOI: 10.1186/s12935-023-03039-w.
Antileishmanial potentials of azacitidine and along with meglumine antimoniate on Leishmania major: In silico prediction and in vitro analysis.
Derakhshani A, Sharifi I, Salarkia E, Keyhani A, Agha Kuchak Afshari S, Iranmanesh B
PLoS One. 2023; 18(9):e0291321.
PMID: 37682979
PMC: 10490874.
DOI: 10.1371/journal.pone.0291321.
Multi-omic analysis reveals dynamic changes of three-dimensional chromatin architecture during T cell differentiation.
Zhang G, Li Y, Wei G
Commun Biol. 2023; 6(1):773.
PMID: 37488215
PMC: 10366224.
DOI: 10.1038/s42003-023-05141-1.
Deficiencies and Dysregulation of STAT Pathways That Drive Inborn Errors of Immunity: Lessons from Patients and Mouse Models of Disease.
Toth K, Schmitt E, Cooper M
J Immunol. 2023; 210(10):1463-1472.
PMID: 37126806
PMC: 10151837.
DOI: 10.4049/jimmunol.2200905.
Dynamic chromatin accessibility licenses STAT5- and STAT6-dependent innate-like function of T9 cells to promote allergic inflammation.
Son A, Meylan F, Gomez-Rodriguez J, Kaul Z, Sylvester M, Falduto G
Nat Immunol. 2023; 24(6):1036-1048.
PMID: 37106040
PMC: 10247433.
DOI: 10.1038/s41590-023-01501-5.
The ins and outs of innate and adaptive type 2 immunity.
Molofsky A, Locksley R
Immunity. 2023; 56(4):704-722.
PMID: 37044061
PMC: 10120575.
DOI: 10.1016/j.immuni.2023.03.014.
Studies on the role of non-coding RNAs in controlling the activity of T cells in asthma.
Sufianov A, Bessonova M, Begliarzade S, Kudriashov V, Danilov A, Ilyasova T
Noncoding RNA Res. 2023; 8(2):211-217.
PMID: 36865391
PMC: 9972402.
DOI: 10.1016/j.ncrna.2023.02.004.
Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints.
Franzese O, Graziani G
Cancers (Basel). 2022; 14(22).
PMID: 36428727
PMC: 9688455.
DOI: 10.3390/cancers14225633.
A pan-cancer analysis of the expression of STAT family genes in tumors and their relationship to the tumor microenvironment.
Zhou M, Zhang P, Da M, Yang R, Ma Y, Zhao J
Front Oncol. 2022; 12:925537.
PMID: 36176415
PMC: 9513395.
DOI: 10.3389/fonc.2022.925537.
Conventional and pathogenic Th2 cells in inflammation, tissue repair, and fibrosis.
Kokubo K, Onodera A, Kiuchi M, Tsuji K, Hirahara K, Nakayama T
Front Immunol. 2022; 13:945063.
PMID: 36016937
PMC: 9395650.
DOI: 10.3389/fimmu.2022.945063.